JAK inhibitors in refractory juvenile idiopathic arthritis-associated uveitis

International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001.

Ross E. Petty, T. R. E. Southwood, Prudence Manners et al. · PubMed · 2004 · 4.2K citations · Full text

Medicine, Clinical Sciences, Pediatric Rheumatology +9

Tofacitinib for Psoriatic Arthritis in Patients with an Inadequate Response to TNF Inhibitors

Dafna D. Gladman, William F. C. Rigby, Valderílio Feijó Azevedo et al. · New England Journal of Medicine · 2017 · 508 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Consensus-based recommendations for the management of uveitis associated with juvenile idiopathic arthritis: the SHARE initiative

Tamás Constantin, Ivan Foeldvari, Jordi Antón et al. · Annals of the Rheumatic Diseases · 2018 · 207 citations · Full text

Medicine, Clinical Sciences, Pediatrics +14

Tofacitinib for refractory uveitis and scleritis

Michael Paley, Hümeyra Karacal, P. Kumar Rao et al. · American Journal of Ophthalmology Case Reports · 2018 · 124 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +14

Evidence for Tocilizumab as a Treatment Option in Refractory Uveitis Associated with Juvenile Idiopathic Arthritis

Christoph Tappeiner, Marina Mesquida, Alfredo Adán et al. · The Journal of Rheumatology · 2016 · 116 citations · Full text

Medicine, Immunology, Pharmacotherapy +14